High-potency probiotic with 450 billion live bacteria per packet. Intended for the dietary management of patients with ulcerative colitis (UC), an Ileal Pouch (IP), and irritable bowel syndrome (IBS)
Published studies suggest that daily ingestion of VSL#3 DS can aid in the dietary management of Ulcerative Colitis (UC) in both adults and pediatric patients. These studies have also demonstrated that VSL#3 DS can be utilized along with standard pharmaceutical UC therapies such as 5-ASA, immunosuppressants, immunomodulatory drugs and steroids.
VSL#3 DS sachets contain Lactic acid bacteria, maltose, silicon dioxide, non-fat dry milk. The lactic acid bacteria in VSL#3 DS are grown in culture mediums that use non-fat dry milk as a fermentation nutrient. Species include:
Published studies suggest that daily ingestion of VSL#3 DS can aid in the dietary management of Ulcerative Colitis (UC) in both adults and pediatric patients. These studies have also demonstrated that VSL#3 DS can be utilized along with standard pharmaceutical UC therapies such as 5-ASA, immunosuppressants, immunomodulatory drugs and steroids.
VSL#3 DS sachets contain Lactic acid bacteria, maltose, silicon dioxide, non-fat dry milk. The lactic acid bacteria in VSL#3 DS are grown in culture mediums that use non-fat dry milk as a fermentation nutrient. Species include:
- Bifidobacterium breve.
- Bifidobacterium longum.
- Bifidobacterium infantis.
- Lactobacillus acidophilus.
- Lactobacillus plantarum.
- Lactobacillus paracasei.
- Lactobacillus bulgaricus.
- Streptococcus thermophilus.
